Cargando…

Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience

INTRODUCTION: Madrid has been the epicenter of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in Spain. We analyzed our experience with SARS-CoV-2 infected and cancer patients. PATIENTS AND METHODS: We included patients from March 1 to April 30 2020 at Hospital Universitar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvo, Virginia, Fernandez-Cruz, Ana, Nuñez, Beatriz, Blanco, Mariola, Morito, Ana, Martínez, Marta, Traseira, Cristina, Garitaonaindía, Yago, Aguado, Ramon, Ramos, Arturo, Royuela, Ana, Franco, Fernando Fabio, Provencio, Mariano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143958/ https://www.ncbi.nlm.nih.gov/pubmed/34040447 http://dx.doi.org/10.2147/CLEP.S308437

Ejemplares similares

Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I–IIIA NSCLC
por: Garitaonaindia, Yago, et al.
Publicado: (2023)

P09.12 SARS- CoV2 Impact in a Spanish Lung Cancer Cohort?
por: Nunez-Garcia, B., et al.
Publicado: (2021)

Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
por: Rodríguez-Cano, Fernando, et al.
Publicado: (2023)

Patterns and outcome of unplanned care in lung cancer patients: an observational study in a medical oncology department
por: Sánchez, Juan C., et al.
Publicado: (2023)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
por: Torrente, María, et al.
Publicado: (2022)

1733P Real-world data: Cancer and SARS-CoV-2 infection
por: Nunez Garcia, B., et al.
Publicado: (2020)

P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
por: Cudero, L., et al.
Publicado: (2021)

Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data
por: Calvo, Virginia, et al.
Publicado: (2021)

Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma
por: Blanco, Mariola, et al.
Publicado: (2022)

Long-term follow up of Hodgkin lymphoma
por: Perez-Callejo, David, et al.
Publicado: (2018)

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review
por: Ortega-Franco, Ana, et al.
Publicado: (2020)

To burn-out or not to burn-out: a cross-sectional study in healthcare professionals in Spain during COVID-19 pandemic
por: Torrente, Maria, et al.
Publicado: (2021)

Next-generation sequencing to dynamically detect mechanisms of resistance to ALK inhibitors in ALK-positive NSCLC patients: a case report
por: Sánchez-Herrero, Estela, et al.
Publicado: (2020)

EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
por: Garitaonaindía Díaz, Y., et al.
Publicado: (2022)

An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study
por: Torrente, María, et al.
Publicado: (2022)

Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis
por: Páez-Guillán, Emilio-Manuel, et al.
Publicado: (2021)

Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients
por: Provencio, Mariano, et al.
Publicado: (2017)

ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib
por: Romero, Atocha, et al.
Publicado: (2020)

An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement
por: Maximiano, Constanza, et al.
Publicado: (2018)

Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
por: Calvo, Virginia, et al.
Publicado: (2021)

Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment
por: Provencio, Mariano, et al.
Publicado: (2017)

Resonance frequency analysis-reliability in third generation instruments: Osstell mentor®
por: Herrero-Climent, Mariano, et al.
Publicado: (2012)

Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
por: Martín Ramos, Silvia, et al.
Publicado: (2020)

SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)
por: Gumà, Josep, et al.
Publicado: (2023)

Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
por: Fernández-Miranda, Ismael, et al.
Publicado: (2023)

CB(2) cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
por: Martínez-Martínez, Esther, et al.
Publicado: (2016)

Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications
por: de la Cruz-Merino, Luis, et al.
Publicado: (2012)

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial
por: Sierra-Rodero, Belén, et al.
Publicado: (2021)

Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)
por: Franco, Fernando, et al.
Publicado: (2021)

PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2017)

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients
por: Provencio, Mariano, et al.
Publicado: (2017)

Hypoxic Treatment Decreases the Physiological Action of the Herbicide Imazamox on Pisum sativum Roots
por: Gil-Monreal, Miriam, et al.
Publicado: (2020)

Survival following vertebral compression fractures in population over 65 years old
por: Gutiérrez-González, Raquel, et al.
Publicado: (2023)

The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2021)

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
por: Provencio, Mariano, et al.
Publicado: (2022)

Predicting the evolution of neck pain episodes in routine clinical practice
por: Kovacs, Francisco M., et al.
Publicado: (2019)

Physician-Related Variability in the Outcomes of an Invasive Treatment for Neck and Back Pain: A Multi-Level Analysis of Data Gathered in Routine Clinical Practice
por: Royuela, Ana, et al.
Publicado: (2021)

Protein kinase GCN2 mediates responses to glyphosate in Arabidopsis
por: Faus, Isabel, et al.
Publicado: (2015)

Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry
por: Provencio, Mariano, et al.
Publicado: (2017)

Detecting ALK , ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques
por: Giménez‐Capitán, Ana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tb1usl0ns1qbemuemd1tkq38nk